Intestinal microbial communities associated with acute enteric infections and disease recovery
© Singh et al. 2015
Received: 18 May 2015
Accepted: 11 September 2015
Published: 22 September 2015
The intestinal microbiome represents a complex network of microbes that are important for human health and preventing pathogen invasion. Studies that examine differences in intestinal microbial communities across individuals with and without enteric infections are useful for identifying microbes that support or impede intestinal health.
16S rRNA gene sequencing was conducted on stool DNA from patients with enteric infections (n = 200) and 75 healthy family members to identify differences in intestinal community composition. Stools from 13 patients were also examined post-infection to better understand how intestinal communities recover. Patient communities had lower species richness, evenness, and diversity versus uninfected communities, while principle coordinate analysis demonstrated close clustering of uninfected communities, but not the patient communities, irrespective of age, gender, and race. Differences in community composition between patients and family members were mostly due to variation in the abundance of phyla Proteobacteria, Bacteroidetes, and Firmicutes. Patient communities had significantly more Proteobacteria representing genus Escherichia relative to uninfected communities, which were dominated by Bacteroides. Intestinal communities from patients with bloody diarrhea clustered together in the neighbor-joining phylogeny, while communities from 13 patients’ post-infection had a significant increase in Bacteroidetes and Firmicutes and clustered together with uninfected communities.
These data demonstrate that the intestinal communities in patients with enteric bacterial infections get altered in similar ways. Furthermore, preventing an increase in Escherichia abundance may be an important consideration for future prevention strategies.
Keywords16S rRNA Intestinal microbiome Enteric pathogens
In the US, diarrheal diseases are mostly caused by 31 different foodborne pathogens and were reported to contribute to 9.4 million infections, 55,961 hospitalizations, and 1351 deaths each year . Among the bacterial infections reported to FoodNet sites between 2000 and 2008, nontyphoidal Salmonella spp. predominated (11 %) followed by Clostridium perfringens (10 %) and Campylobacter spp. (9 %). Shiga toxin-producing Escherichia coli (STEC) O157 and non-O157 also caused 0.7 and 0.6 % of infections, respectively, while Shigella spp. caused 1.4 % during this same time frame . In humans, these pathogens can result in asymptomatic colonization, nonbloody diarrhea, or hemorrhagic colitis , though they have also been linked to more severe complications. STEC, for example, can cause hemolytic uremic syndrome (HUS), which may result in kidney failure and death, while C. jejuni can cause neuropathies (e.g., Guillain Barré Syndrome) and paralysis [3, 4] in a subset of patients. Although the virulence and characteristics of a given pathogen influences disease outcomes, the interaction between the pathogen and host environment is also critical. Little is known, however, about how the microbiota impacts enteric disease susceptibility, severity, and recovery.
Human intestinal communities were previously suggested to comprise >1012 microbes/ml  with key functions including protection from pathogen proliferation, synthesizing essential nutrients, metabolizing by-products, processing indigestible products from the human diet, and immunomodulation [6, 7]. Members of two phyla, the Bacteroidetes and Firmicutes, have been found to dominate in the intestines of healthy individuals, though considerable variation has been observed . Prior studies have also demonstrated that intestinal communities are stable over time  and that several factors including diet, lifestyle, age, probiotic and antibiotic use, infection, and chronic conditions [10–12], can significantly alter the diversity and abundance of the intestinal microbiota. In patients with inflammatory bowel disease (IBD), for instance, a decrease in the abundance of Bacteroidetes and Lachnospiraceae has been observed , while bile acid profiles associated with animal- versus plant-based diets were associated with growth inhibition of Bacteroidetes and Firmicutes . Decreased abundance of members belonging to both Bacteroidetes and Firmicutes was suggested to result in enhanced susceptibility to enteric infections as it shifts the microbial balance away from a healthy state. A prior study in mice demonstrated that intestinal communities with a high abundance of species closely related to pathogens were more likely to be affected by those pathogens . Communities with a high abundance of commensal E. coli, for example, were more susceptible to inflammation induced by Salmonella enterica infections, whereas diverse intestinal communities were more resistant to infection. Commensal microbes were also suggested to alter pathogen virulence gene expression profiles by modifying environmental conditions . These data underlie the importance of intestinal communities in both promoting and inhibiting pathogen proliferation; however, additional studies are needed to identify which communities are most susceptible to and protective against infection and how they change with infection.
Several studies have also demonstrated that intestinal communities are capable of recovering following perturbations. In mice infected with Citrobacter rodentium, a model for human enterohemorrhagic and enteropathogenic E. coli infections, alterations in the composition and abundance of the intestinal microbiota could be restored to a pre-infection state upon elimination of the pathogen . Similarly, restoration of intestinal communities disrupted during antibiotic use has also been observed soon after antibiotic cessation [17, 18].
Despite the recent interest and research on the intestinal microbiome, few population-based human studies have been conducted to better understand how the microbiota is impacted by enteric pathogens with different lifestyles. Here, we have compared the composition and abundance of intestinal microbes between patients with acute enteric infections and their uninfected family members by 16S rRNA sequencing. We have also examined how the intestinal microbial communities from a subset of patients change up to 14 weeks post-recovery, and have identified specific microbial populations that are correlated with clinical symptoms.
Enteric disease cases identified via active surveillance are representative of the Michigan population
As part of the Enteric Research Investigative Network (ERIN) Cooperative Research Center (CRC) at Michigan State University, we developed an active surveillance system to identify patients with enteric infections at four participating hospitals and the Michigan Department of Health and Human Services (MDHHS). To ensure that the ERIN surveillance network is representative of statewide enteric infection frequencies and that our results are generalizable, we compared the frequency of all ERIN cases (n = 615) identified between January 1, 2011 and May 7, 2014 to all cases (n = 7435) identified throughout the State of Michigan during the same time period. For each pathogen, the frequency of cases was similar even after stratifying by gender, though a difference was observed after stratifying by age group (data not shown). Because the ERIN network targeted hospitals with the largest pediatric populations, we have captured more pediatric cases, particularly those in the youngest age group.
A total of 310 stool samples were included for 16S rRNA sequencing analysis. These stools originated from 200 patients infected with Campylobacter (n = 71), Salmonella (n = 66), Shigella (n = 34), and STEC (n = 28); the pathogen was not known for one patient. A total of 75 stools from otherwise healthy family members were also included for comparison, with 64 (85 %) representing 22 families ranging in size between two and six participants.
Intestinal microbial communities are distinct between patients with enteric disease and healthy family members
To further demonstrate that the differences observed across patients infected with the different pathogens were not attributable solely to an increase in the abundance of the actual pathogen, we also examined genera abundance and composition across patients. Notably, genus Escherichia predominated across communities regardless of the pathogen causing the infection (Additional file 3: Figure S3), though the highest levels were found in STEC cases. The similarity percentages (SIMPER) analysis demonstrated that Escherichia was responsible for the highest average dissimilarity (10.9) across the infected communities relative to the uninfected communities. The mean abundance of Escherichia in communities infected with Campylobacter, Salmonella, Shigella and STEC was 0.21, 0.14, 0.24, and 0.21, respectively, relative to uninfected communities (0.01). More specifically, the population of Gammaproteobacteria from Campylobacter cases represented 29 genera with Escherichia comprising 60 % followed by Trabulsiella (7 %) and unclassified Pseudomonadaceae (7 %). Genus Campylobacter was only detected on average in 0.01 % of 41 of the 71 Campylobacter cases, which represented 3.7 % of the total Proteobacteria levels. Salmonella cases had 27 genera represented from Gammaproteobacteria with Escherichia and Trabulsiella predominating at 45 and 21 %, respectively, followed by Citrobacter (12 %) and unclassified Enterobacteriaceae (10 %). Only 22 of the 66 Salmonella cases had detectable levels (average 0.002 %) of genus Salmonella, which represented 0.52 % of the total Proteobacteria levels. For STEC cases, 21 genera were identified with Escherichia comprising 77 % of the Gammaproteobacteria population identified, which represented the total level of Proteobacteria detected in these cases. A total of 23 genera were detected in Shigella cases with most belonging to Escherichia (69 %), unclassified Pseudomonadaceae (8 %), and Klebsiella (6 %). Genus Shigella was not detected in any of the cases, though unclassified Enterobacteriaceae was found at an average of 0.007 %. None of the cases had levels of unclassified Enterobacteriaceae exceeding 10 %. Together, these data demonstrate that the distribution of genera differed among the intestinal communities from patients, which was also indicated in the NPMANOVA analysis; however, Escherichia predominated in most infected communities regardless of the pathogen causing the infection.
Similar findings were observed utilizing the linear discriminant analysis (LDA) effect size (LEfSe) method , which identified 14 microbial features (LDA > 2.4) to be differentially abundant in the patient communities relative to uninfected communities (Additional file 3: Figure S4). Among infected versus uninfected communities, the most abundant features at the family level were Enterobacteriaceae followed by Pateurellaceae, Lactobacillales, Streptococcaceae, and Lachnospiraceae. At the genus level, Bacteroides dominated in 86.7 % of the samples from healthy family members with a range between 6 and 75 %, while Prevotella were found in 13.3 % with a range of 16 to 65 %. Among the intestinal communities from healthy individuals, a total of 38 microbial features were differentially abundant. At the family level, most of these features were classified as Rikenellaceae, Bacteroidaceae, Ruminococcaceae, Porphyromonadaceae, Bifidobacteriaceae, Alcaligenaceae, Odoribacteraceae, Barnesiellaceae, and Lachnospiraceae. The genera Roseburia, Lachnospira, and Blautia of the Lachnospiraceae family were most abundant in healthy family members compared to patients. Overall, no microbial features were differentially abundant in the communities of patients infected with different pathogens.
Hierarchical clustering indicates that intestinal microbial communities from patients with enteric infections are similar
At the phyla level, clusters I/II had significantly different microbiota profiles in both the weighted and unweighted analysis (NPMANOVA, P < 0.0001) when compared to clusters III–V. A significantly higher average percentage of phylum Proteobacteria (42 %) was observed in clusters I/II relative to clusters III–V (6 %), while Bacteroidetes (38 %) and Firmicutes (17 %) were more common in the latter three clusters. Among the uninfected communities belonging to clusters III–V, the abundance of Bacteroidetes (59 %) and Firmicutes (33 %) was even higher. Significant differences were also observed at the genus level. Intestinal communities representing clusters I and II (n = 160) were dominated by Escherichia, Trabulsiella, Citrobacter, unclassified Pseudomonadaceae, or Bacteroides, whereas communities of clusters III–V (n = 115) were dominated by Bacteroides or Prevotella. Notably, Escherichia was significantly more abundant in communities belonging to clusters I and II compared to communities of clusters III, IV, and V as were Trabulsiella and unclassified Enterobacteriaceae (P < 0.0001). Bacteroides, Parabacteroides, Faecalibacterium, Roseburia, Ruminococcus, Suturella, and unclassified Lachnospiraceae, however, were significantly more abundant in clusters III–V (Additional file 3: Figure S5). Collectively, these data highlight the differences in the composition and abundance of intestinal microbes across cluster groups and suggest that the microbiota profiles are more similar among patients with enteric infections. No differences in cluster classification were observed across patients infected with different pathogens (Fig. 3).
Specific microbiota profiles are associated with demographics and clinical symptoms
Univariate analaysis highlighting the association between intestinal microbiota profiles and host factors among 200 patients with enteric infections
Community clusters I and II (n = 152)
Community clusters III–V (n = 47)
No. (%) of individuals
No. (%) of individuals
0–2 years (n = 31)
3–18 years (n = 55)
19–52 years (n = 76)
>52 years (n = 37)
Male (n = 104)
Female (n = 93)
No diarrhea (n = 3)
Diarrhea only (n = 91)
Bloody diarrhea (n = 85)
No vomiting (n = 118)
Vomiting (n = 59)
No fever (n = 62)
Fever (n = 99)
Length of hospitalization
None (n = 126)
1–2 days (n = 19)
≥3 days (n = 40)
Type of pathogen (n = 199)
Campylobacter (n = 71)
Salmonella (n = 66)
Shiga toxin E. coli (n = 28)
Shigella (n = 34)
While adjusting for age, gender, and intestinal microbiota profile, logistic regression analyses demonstrated that patients with intestinal communities belonging to clusters I/II were significantly more likely to have bloody diarrhea (odds ratio (OR), 2.3; 95 % CI, 1.12, 4.82). Male gender, however, resulted in a protective effect (OR, 0.5; 95 % CI, 0.28, 0.91), and no association was observed for length of hospitalization. Addition of pathogen type to the logistic regression model resulted in similar associations for gender and cluster, but also showed that patients with STEC infections were significantly more likely to have bloody diarrhea when compared to patients with Salmonella, Shigella, and Campylobacter (OR, 3.7; 95 % CI, 1.37, 9.79). Nonetheless, these data suggest that individuals with more severe disease, as measured by the presence of bloody diarrhea, were more likely to have intestinal communities with similar profiles regardless of age and infection by three of the four pathogens.
The intestinal microbial communities of patients up to 14 weeks post-infection mimics the intestinal communities of healthy family members
Although the microbial communities of the human gut have been found to be both complex and diverse with considerable variation across individuals [6, 8], our examination of the intestinal microbiota from patients with enteric infections has shown a decreased diversity relative to intestinal communities from healthy individuals. This finding is not surprising in that individuals suffering from acute diarrhea can lose up to 200 g of stool and fluids each day , thereby inducing a significant change to the intestinal microbiome. Through this study, however, we have demonstrated that patients with acute enteric infections caused by four different bacterial pathogens have similar deficiencies in the abundance of certain intestinal microbes. It is therefore likely that specific microbial populations are more commonly selected for during the course of an infection, and that restoring intestinal health relies on the time it takes these intestinal communities to recover and shift back to a pre-infection or healthy state.
Irrespective of the bacterial pathogen that caused each infection, a greater abundance of Proteobacteria and lower abundance of Bacteroidetes and Firmicutes was detected in the patients’ (infected) intestinal communities when compared to the uninfected communities of healthy family members. Both Bacteroidetes and Firmicutes have previously been associated with intestinal health , and all patients in this study had significantly lower levels of both phyla relative to uninfected family members. In addition, among the 200 patients with enteric infections, 63.5 % of the population had communities comprising >20 % Proteobacteria compared to an average of only 4.3 % of the healthy individuals (n = 75). Although the total number and relative abundance of OTUs uncovered in the intestinal communities from individuals were lower than in prior studies, all stool samples were preserved in the same conditions with Cary-Blair media, which had little effect on the presence and abundance of specific community members following experimental inoculation of cattle feces (Additional file 3: Figure S9). Because each intestinal community was similarly affected by the preservation media, differences could be identified and comparisons could be made across individuals with and without disease. Likewise, given the challenges associated with DNA recovery from gram-positive bacteria, it is possible that the abundance of specific community members may have been underestimated. Since the same DNA isolation protocol, which incorporated a recommended mechanical disruption step , was utilized for each stool sample and high frequencies of gram-positive bacteria were recovered from many samples, we do not expect that the differential recovery of these bacteria in the uninfected versus infected samples contributed to bias in this study. In addition, our results showing increased levels of Proteobacteria in infected communities are similar to those generated in prior studies and suggest that enhanced Proteobacteria may be indicative of a diseased state that commonly occurs during enteric infections or following perturbations in the microbiota. One previous study, for example, observed an overgrowth of Enterobacteriaceae after C. rodentium infection in mice due to microbiota depletion and induction of host inflammatory responses , while patients with inflammatory bowel disease had increased levels of Enterobacteriaceae  or Proteobacteria  relative to healthy controls.
Since the majority of Proteobacteria represented genus Escherichia among all patients with enteric infections regardless of the bacterial pathogen causing the infection, it is likely that this microbial population is more frequently selected for during an acute enteric infection. Factors that contribute to an increase in specific microbes over others, however, are not fully understood, though we do know that microbiota depletion and host immune responses are likely to be critical. Salmonella typhimurium, for instance, was shown to outcompete the host microbiota by exploiting host inflammatory immune responses  and utilizing luminal thiosulfate from the reactive oxygen species generated during inflammation . Similarly, enterohemorrhagic E. coli and enteropathogenic E. coli were shown to accept nitrate produced by host innate immune cells for use as energy via anaerobic respiration to enhance survival in the inflamed mouse intestine . Because members of Bacteroidetes and Firmicutes cannot utilize nitrate, it was suggested that the microbial balance becomes disrupted by promoting overgrowth of both pathogenic and commensal E. coli following inflammation . Our study provides additional support for these findings and suggests that infection with not only pathogenic E. coli induces an increase in Escherichia levels within infected intestinal communities. Increases were also observed in patients infected with Campylobacter, Salmonella and Shigella. Interestingly, STEC patients had the highest levels of Escherichia as compared to patients with Campylobacter, Shigella, and Salmonella infections, suggesting that both the pathogenic STEC and commensal Escherichia population were selected for at the time of the infection. In addition, the decrease in Proteobacteria levels among the 13 patients following recovery from infection demonstrates that the increase in Proteobacteria levels occurred during the acute infection and that healthy levels are significantly lower. A study of Cholera reported similar findings as Proteobacteria was more abundant during the acute stage of Cholera infections in nine children when compared to 28 days post-infection .
In addition to the decreasing level of Proteobacteria belonging to genus Escherichia identified in a subset of patients post-infection, we also observed significant increases in phyla Firmicutes and Bacteroidetes, which were not significantly different from levels in healthy family members. These results are consistent with prior reports demonstrating that intestinal communities recover following perturbations. Several studies, for instance, have documented a shift in intestinal communities during periods of antibiotic use with recovery of those communities occurring soon after antibiotic cessation [17, 18]. Other studies have also shown that disruptions in intestinal microbial communities can result in enhanced susceptibility to pathogen colonization, invasion, and infection . Future studies, however, are needed to determine whether certain communities are more susceptible to severe perturbation than others. Here, we observed greater increases in Proteobacteria and Escherichia levels in some patients and not others, though logistic regression analyses did not link either high Proteobacteria or Escherichia abundance with clinical symptoms. Conversely, we found that patients with intestinal community profiles belonging to clusters I/II were significantly more likely to report a history of bloody diarrhea than patients with distinct communities. These patients were also significantly more likely to be male, suggesting that the complete microbiota profile of the cluster I/II communities are more important for dictating disease outcomes during an acute infection than the increased level of Escherichia. Because our sequencing analyses focused on 16S rRNA genes, a more comprehensive metagenomic analysis is warranted between these patient and family member communities to better define which microbes comprise clusters I/II and III–V, and identify relationships between complete microbiome profiles and disease severity.
Collectively, the data presented herein demonstrate that intestinal microbial communities become affected in a similar way among patients with enteric infections regardless of the pathogen type and age of the patient. Perturbations of specific communities (e.g., Cluster I/II) that are characterized by an increase in Escherichia are more likely to have more severe symptoms; hence, it is possible that these communities with a higher abundance of Escherichia take longer to recover to a healthy state. Future studies should therefore focus on characterizing the population of Escherichia as it is not clear whether there is overgrowth of one strain type or if the population is diverse consisting of genetically distinct strains. Based on our data, it is also important to consider future treatment strategies that involve the use of probiotics or therapeutics that aim to increase the abundance of beneficial microbes comprising Bacteroidetes and Firmicutes and more rapidly decrease Proteobacteria populations. Such strategies could potentially decrease the burden of enteric infections and facilitate a quicker recovery.
Enhancing our understanding of how intestinal microbial communities change during an enteric infection and identifying factors that influence these changes are important for the development of novel prevention and treatment strategies. In our analysis of 200 intestinal communities from patients and 75 healthy family members, we found that specific intestinal microbiota are more common among patients during an acute enteric infection regardless of the type of enteric pathogen. Specifically, the intestinal microbial communities from patients were more frequently dominated by Proteobacteria and not Bacteroidetes and Firmicutes, which represent dominant commensals and the most common phyla in human intestinal communities. Patients with similar microbiota profiles were more likely to have severe disease outcomes, suggesting that increases in specific microbe populations, which were primarily attributable to Escherichia, occur during an infection. This finding is supported by the result that patient intestinal communities recovered over time to mimic those communities of healthy family members, which were classified by an increase in phyla Bacteroidetes and Firmicutes and decrease in Proteobacteria belonging to genus Escherichia. Future enteric disease prevention strategies could therefore aim to decrease intestinal Escherichia levels at the time of an acute infection while simultaneously boosting microbes including Bacteroidetes that are most important for restoring intestinal health.
An active surveillance system was created through the MDHHS Bureau of Laboratories to identify 200 patients infected with Campylobacter, Salmonella, Shigella, and STEC at four participating Michigan hospitals. Surveillance began on January 1, 2011. Stools from each patient were added to Cary-Blair transport media and submitted to the MDHHS for de-identification, culture, and transport to MSU for community DNA isolation and 16S rRNA sequencing. Family members of patients (n = 75) were enrolled by phone and asked to submit a stool specimen preserved in Cary-Blair transport media and to complete a questionnaire containing demographic information, exposures (e.g., animal contacts, travel history), and signs of illness including duration, type, and severity of clinical symptoms. Such information was also available for each patient through the Michigan Disease Surveillance Network (MDSS) maintained by the MDHHS Bureau of Epidemiology. A subset of 13 patients was also re-contacted post-infection for stool submission and questionnaire completion. Each participant was required to provide informed consent prior to enrollment and was given a monetary incentive after samples were received at MDHHS. All protocols were approved by the Institutional Review Boards at MSU (IRB# 10-736SM), the MDHHS (842-PHALAB), and each of the four participating hospitals (RR#12170, University of Michigan; 202749-6 Sparrow Health System; 2011-039 Spectrum Health, and 022111MP4E, Wayne State University/Detroit Medical Center).
DNA isolation and sample preparation
Stool samples were processed soon after receipt by both MDHHS and MSU and time period from collection to processing was noted. Following homogenization and centrifugation, aliquots of stool were stored in triplicate at −80 °C until further use. A total of 310 stools were examined in this analysis, which represent 41.8 % of the total number of stools (n = 741) received via the ERIN surveillance system through May 7, 2011. Stool DNA recovery (260/280 nm) and yield (ng/μl) were initially compared using the QIAamp DNA Stool Mini Kit (QIAGEN; Valencia, CA) and the MoBio Fecal Isolation Kit (MoBio; Carlsbad, CA) and standardized using the NanoDrop (Thermo Fischer Scientific). Four stools were compared using the manufacturer’s instructions, except for the addition of a denaturation step (95 °C) followed by bead beating for the QIAamp kit to enhance DNA isolation of gram-positive bacteria as described . Samples were also evaluated for changes before and after homogenization. Overall, the QIAamp kit resulted in better quality yields, enhanced diversity (Additional file 3: Figure S10), and better recovery of phyla representing gram-positive bacteria (Additional file 3: Figure S11). Hence, the QIAmp protocol was used for the remaining 306 samples. No differences were observed between communities from the same individual before and after homogenization.
Because all stool samples were transported in Cary-Blair media to preserve the pathogens for culture, we wanted to ensure that the preservation media did not alter the composition of the microbiota (Additional file 3: Figure S9). To do this, we incubated cattle feces obtained through a different study with and without Cary-Blair at 4 °C for up to 4 days; we did not have access to unpreserved human samples. Four days represented the average length of time for human samples to reach our laboratory from the MDHHS prior to isolating community DNA. Pyrosequencing was performed on both sets of samples for comparison.
Pyrosequencing and community analysis
Isolated community DNA was amplified for the 16S rRNA gene spanning the V5–V3 regions using universal primers 357F and 926R tagged with the 454 universal primers A and B at either end with barcodes for multiplexing samples. PCR amplification was performed using AccuPrime™ Taq DNA polymerase (Invitrogen™) in triplicate with initial denaturation at 95 °C for 2 min followed by 30 cycles of 95 °C for 20 s, 50 °C for 30 s, and 72 °C for 5 min. An amplicon library of 48 communities were prepared for each sequencing run on 454 GS Junior Titanium chemistry, by individually purifying the product using the Agencourt AMPure XP (Beckman Coulter, Inc.) beads, quanitification by pico green assays (Quant-iT™ PicoGreen® dsDNA quanititation kit, Invitrogen™) followed by normalization and pooling.
Over 1 million reads were processed in the Quantitative Insights Into Microbial Ecology (QIIME) software  and aligned and classified using the Greengenes 16S rRNA gene reference database. Sequence data were subjected to quality trimming, filtering, and noise reduction by QIIME denoiser using the default parameters . The unaligned sequences were eliminated followed by chimeric sequences and singleton removal using the USEARCH quality filtering included in QIIME and the data have been analyzed for microbial community composition, diversity, and richness . OTUs were clustered at 97 % similarity cutoff using USEARCH where 16S rDNA sequences were classified using the Greengenes database. Rarefaction curves were constructed using QIIME  based on the observed OTUs in infected and uninfected stool samples, Shannon diversity index, and the Chao1 richness estimator. The OTU biome table from QIIME was used in Mothur to calculate richness and evenness indices with 95 % confidence intervals (Additional file 1: Tables S1 and Additional file 2: Table S2) as described previously . LEfSe was then used to identify differentially abundant microbial features as described previously . UniFrac distances were calculated in QIIME for both abundance and composition and 3D principal coordinate analysis plots were generated using KING (Kinemage, Next Generation) .
Hierarchical clustering analysis and epidemiological analyses
The phylogenetic data from QIIME was further analyzed using Paleontological Statistics Software Package For Education and Data Analysis (PAST) based on the NPMANOVA and to calculate genera important for dissimilarities between groups using SIMPER. Additional 2D principal coordinate analysis plots based on both the Bray-Curtis and Jaccard similarity coefficients were also constructed for a weighted and unweighted analysis (28). Box plots were constructed using SigmaPlot 10.0.
Links to epidemiological data were made after clustering relationships were identified between the stool communities based on abundance profile calculated by Bray-Curtis dissimilarity index in PAST for generation of neighbor-joining tree followed by tree construction in FigTree (http://tree.bio.ed.ac.uk/software/figtree/). We tested for differences in the frequency of clinical characteristics including HUS, diarrhea, bloody diarrhea as well as for various factors including age and gender, across the different microbial community clusters using the likelihood chi-square test or Mantel-Haenszel chi-square (for variables with more than two outcomes) distributions using odds ratios with 95 % confidence intervals performed with Statistical Analysis Software (SAS) (version 9.3).
Availability of supporting data
This work was supported by the NIH Enterics Research Investigational Network Cooperative Research Center at Michigan State University (U19AI090872) and in part by the USDA NIFA (2011-67005-30004) and Michigan State University. We would like to thank Sandip Shah, Ben Hutton, Jason Wholehan, Sheri Robeson, Tiffany Henderson, and James Collins at the MDHHS and the laboratory staff at each participating hospital for help with specimen processing and culture as well as Kylie Farrel and Chris Radek for sequencing assistance.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, et al. Foodborne illness acquired in the United States—major pathogens. Emerg Infect Dis. 2011;17(1):7–15. doi:10.3201/eid1701.091101p1.PubMed CentralView ArticlePubMedGoogle Scholar
- Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365(9464):1073–86.PubMedGoogle Scholar
- Nachamkin I, Allos BM, Ho T. Campylobacter species and Guillain-Barre syndrome. Clin Microbiol Rev. 1998;11(3):555–67.PubMed CentralPubMedGoogle Scholar
- Willison HJ, Plomp JJ. Anti-ganglioside antibodies and the presynaptic motor nerve terminal. Ann N Y Acad Sci. 2008;1132:114–23.View ArticlePubMedGoogle Scholar
- Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977;31:107–33.View ArticlePubMedGoogle Scholar
- Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307(5717):1915–20.View ArticlePubMedGoogle Scholar
- O’Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7(7):688–93. doi:10.1038/sj.embor.7400731.PubMed CentralView ArticlePubMedGoogle Scholar
- Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635–8. doi:10.1126/science.1110591.PubMed CentralView ArticlePubMedGoogle Scholar
- Martinez I, Muller CE, Walter J. Long-term temporal analysis of the human fecal microbiota revealed a stable core of dominant bacterial species. PLoS ONE. 2013;8(7):e69621. doi:10.1371/journal.pone.0069621.PubMed CentralView ArticlePubMedGoogle Scholar
- Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut. 2001;48(2):198–205.PubMed CentralView ArticlePubMedGoogle Scholar
- Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6(11):e280. doi:10.1371/journal.pbio.0060280.PubMed CentralView ArticlePubMedGoogle Scholar
- Peterson DA, Frank DN, Pace NR, Gordon JI. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe. 2008;3(6):417–27. doi:10.1016/j.chom.2008.05.001.PubMed CentralView ArticlePubMedGoogle Scholar
- David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–63. doi:10.1038/nature12820.PubMed CentralView ArticlePubMedGoogle Scholar
- Stecher B, Chaffron S, Kappeli R, Hapfelmeier S, Freedrich S, Weber TC, et al. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog. 2010;6(1):e1000711. doi:10.1371/journal.ppat.1000711.PubMed CentralView ArticlePubMedGoogle Scholar
- Kamada N, Chen GY, Inohara N, Nunez G. Control of pathogens and pathobionts by the gut microbiota. Nature Immunol. 2013;14(7):685–90. doi:10.1038/ni.2608.View ArticleGoogle Scholar
- Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe. 2007;2(3):204.View ArticlePubMedGoogle Scholar
- Young VB, Schmidt TM. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol. 2004;42(3):1203–6.PubMed CentralView ArticlePubMedGoogle Scholar
- Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun. 2009;77(6):2367–75. doi:10.1128/IAI.01520-08.PubMed CentralView ArticlePubMedGoogle Scholar
- Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. doi:10.1186/gb-2011-12-6-r60.PubMed CentralView ArticlePubMedGoogle Scholar
- Gadewar S, Fasano A. Current concepts in the evaluation, diagnosis and management of acute infectious diarrhea. Curr Opin Pharmacol. 2005;5(6):559–65. doi:10.1016/j.coph.2005.08.002.View ArticlePubMedGoogle Scholar
- Smith B, Li N, Andersen AS, Slotved HC, Krogfelt KA. Optimising bacterial DNA extraction from faecal samples: comparison of three methods. Open Microbiol J. 2011;5:14–7. doi:10.2174/1874285801105010014.PubMed CentralView ArticlePubMedGoogle Scholar
- Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn’s disease of the colon. Gut. 2003;52(2):237–42.PubMed CentralView ArticlePubMedGoogle Scholar
- Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104(34):13780–5. doi:10.1073/pnas.0706625104.PubMed CentralView ArticlePubMedGoogle Scholar
- Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007;5(10):2177–89.View ArticlePubMedGoogle Scholar
- Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, Crawford RW, et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010;467(7314):426–9. doi:10.1038/nature09415.PubMed CentralView ArticlePubMedGoogle Scholar
- Winter SE, Winter MG, Xavier MN, Thiennimitr P, Poon V, Keestra AM, et al. Host-derived nitrate boosts growth of Escherichia coli in the inflamed gut. Science. 2013;339(6120):708–11. doi:10.1126/science.1232467.PubMed CentralView ArticlePubMedGoogle Scholar
- Monira S, Nakamura S, Gotoh K, Izutsu K, Watanabe H, Alam NH, et al. Metagenomic profile of gut microbiota in children during cholera and recovery. Gut Pathog. 2013;5(1):1. doi:10.1186/1757-4749-5-1.PubMed CentralView ArticlePubMedGoogle Scholar
- Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nature Meth. 2010;7(5):335–6. doi:10.1038/nmeth.f.303.View ArticleGoogle Scholar
- Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26(19):2460–1. doi:10.1093/bioinformatics/btq461.View ArticlePubMedGoogle Scholar
- Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75(23):7537–41. doi:10.1128/AEM.01541-09.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen VB, Davis IW, Richardson DC. KING (Kinemage, Next Generation): a versatile interactive molecular and scientific visualization program. Protein Sci. 2009;18(11):2403–9. doi:10.1002/pro.250.PubMed CentralView ArticlePubMedGoogle Scholar